219 related articles for article (PubMed ID: 4544836)
1. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
[No Abstract] [Full Text] [Related]
2. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
3. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
[No Abstract] [Full Text] [Related]
4. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
5. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
[No Abstract] [Full Text] [Related]
6. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Jaffe N; Frei E; Traggis D; Bishop Y
N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
[No Abstract] [Full Text] [Related]
7. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
[No Abstract] [Full Text] [Related]
8. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
Pratt CB; Roberts D; Shanks EC; Warmath EL
Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
[No Abstract] [Full Text] [Related]
10. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
Jaffe N; Frei E; Watts H; Traggis D
Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
[No Abstract] [Full Text] [Related]
11. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Marroum MC; Huvos AG; Rosen G
Oncology; 1977; 34(6):273-80. PubMed ID: 304199
[TBL] [Abstract][Full Text] [Related]
12. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
Jaffe N
Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
14. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Cohen IJ
Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
[TBL] [Abstract][Full Text] [Related]
15. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
[TBL] [Abstract][Full Text] [Related]
16. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
Beattie EJ; Martini N; Rosen G
Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
[TBL] [Abstract][Full Text] [Related]
17. Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma.
Djerassi I
N Engl J Med; 1975 May; 292(21):1133-4. PubMed ID: 1079317
[No Abstract] [Full Text] [Related]
18. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
Allen JC; Rosen G
Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma--the winds of change.
Mills EE
S Afr Med J; 1978 May; 53(18):695-8. PubMed ID: 308700
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
Lange B; Kramer S; Gregg JR; Toledano S; Wimmer R; Evans AE
Am J Clin Oncol; 1982 Feb; 5(1):3-8. PubMed ID: 6979238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
